Suppr超能文献

抗血栓和抗真菌的N-取代咪唑对大鼠肝微粒体甾体和外源性物质羟化酶的体外比较作用

Comparative effects of antithrombitic and antimycotic N-substituted imidazoles on rat hepatic microsomal steroid and xenobiotic hydroxylases in vitro.

作者信息

Murray M, Zaluzny L

机构信息

Department of Medicine, University of Sydney, Westmead Hospital, NSW, Australia.

出版信息

Biochem Pharmacol. 1988 Feb 1;37(3):415-20. doi: 10.1016/0006-2952(88)90208-0.

Abstract

N-Substituted imidazoles have been shown to be potent inhibitors of microsomal mixed-function oxidase activities in vitro and in vivo. In the present study the effects of two antithrombitic (dazmegrel and dazoxiben) and four antimycotic (ketoconazole, econazole, miconazole and clotrimazole) imidazoles on microsomal cytochrome P-450-mediated steroid and xenobiotic hydroxylases were studied in vitro. Despite the presence of the N-substituted imidazole moiety, the antithrombitic agents were essentially non-potent as inhibitors of all of the oxidase activities evaluated. In contrast, the antimycotic drugs were potent inhibitory compounds. Binding studies revealed that all six imidazoles elicited type II optical difference spectra and exhibited relatively high affinity for ferricytochrome P-450 in microsomal suspensions (Ks range 0.26-0.73 microM for the antimycotic agents and 6.5 microM and 21 microM for dazmegrel and dazoxiben, respectively). The structural feature that the antithrombitic compounds share is a carboxylate function so that, at physiological pH, less than 1% of the drug would be present in the unionised form. This functionality is absent from the structures of the antimycotic agents which possess much greater hydrophobic character. Even though the antithrombitic imidazoles elicit type II binding interactions of quite high affinity it would appear from this study that significant inhibition potency does not necessarily follow. The present findings also suggest that interesting differences exist between the active site binding regions in the cytochrome P-450 that catalyse thromboxane synthetase activity and those involved in microsomal drug oxidation. Inhibitor hydrophobicity is clearly an important factor in the inhibition of microsomal cytochromes P-450 whereas effective thromboxane synthetase inhibitors may be quite hydrophilic at physiological pH.

摘要

N-取代咪唑已被证明在体外和体内都是微粒体混合功能氧化酶活性的有效抑制剂。在本研究中,体外研究了两种抗血栓药物(达美格雷和达唑氧苯)和四种抗真菌药物(酮康唑、益康唑、咪康唑和克霉唑)咪唑对微粒体细胞色素P-450介导的类固醇和异生素羟化酶的影响。尽管存在N-取代咪唑部分,但抗血栓药物作为所有评估的氧化酶活性的抑制剂基本上没有效力。相比之下,抗真菌药物是有效的抑制化合物。结合研究表明,所有六种咪唑都能产生II型光学差异光谱,并且对微粒体悬浮液中的高铁细胞色素P-450表现出相对较高的亲和力(抗真菌药物的Ks范围为0.26 - 0.73微摩尔,达美格雷和达唑氧苯分别为6.5微摩尔和21微摩尔)。抗血栓化合物共有的结构特征是羧酸盐功能,因此在生理pH值下,不到1%的药物将以未离子化形式存在。抗真菌药物的结构中不存在这种功能,它们具有更大的疏水性。尽管抗血栓咪唑引发了具有相当高亲和力的II型结合相互作用,但从这项研究来看,显著的抑制效力不一定随之而来。目前的研究结果还表明,催化血栓素合成酶活性的细胞色素P-450中的活性位点结合区域与参与微粒体药物氧化的区域之间存在有趣的差异。抑制剂疏水性显然是抑制微粒体细胞色素P-450的一个重要因素,而有效的血栓素合成酶抑制剂在生理pH值下可能相当亲水。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验